Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ULTRALIFE CORP Director's Dealing 2024

Apr 19, 2024

34105_dirs_2024-04-19_d4561cb8-0aa0-4a37-a834-270d034d5761.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ULTRALIFE CORP (ULBI)
CIK: 0000875657
Period of Report: 2024-04-17

Reporting Person: FAIN PHILIP A (CFO and Treasurer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-04-17 Common Stock; $.10 par value M 7179 $5.7075 Acquired 137809 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-04-17 Stock Options $5.7075 M 20000 Disposed 2024-04-19 Common Stock (20000) Direct

Footnotes

F1: (1) Represents shares of common stock acquired by the Reporting Person upon exercise of options for 20,000 shares of common stock of the Company, net of 12,821 shares of common stock, retained by the Company at a price determined pursuant to the terms of the Company's 2014 Long Term Incentive Plan, in payment of the exercise price for the options.

F2: (2) Represents exercise of options for 20,000 shares of common stock of the Company.